| For: | Yue T, Lu H, Yao XM, Du X, Wang LL, Guo DD, Liu YM. Elevated serum growth differentiation factor 15 in multiple system atrophy patients: A case control study. World J Clin Cases 2020; 8(12): 2473-2483 [PMID: 32607324 DOI: 10.12998/wjcc.v8.i12.2473] |
|---|---|
| URL: | https://www.wjgnet.com/2307-8960/full/v8/i12/2473.htm |
| Number | Citing Articles |
| 1 |
Xin‐Hong Xue, Lin‐Lin Tao, Dao‐Qing Su, Cun‐Ju Guo, Hong Liu. Diagnostic utility of GDF15 in neurodegenerative diseases: A systematic review and meta‐analysis. Brain and Behavior 2022; 12(2) doi: 10.1002/brb3.2502
|
| 2 |
Tao Nie, Hongmei Song, Xiaofang Shen, Liufeng Mao. GDF15 as a sentinel of metabolic integrity: a narrative review of stress signaling, multisystem pathophysiology, and therapeutic potential. Frontiers in Endocrinology 2026; 17 doi: 10.3389/fendo.2026.1885104
|
| 3 |
Peng-Fei Wu, Xing-Hao Zhang, Ping Zhou, Rui Yin, Xiao-Ting Zhou, Wan Zhang. Growth Differentiation Factor 15 Is Associated With Alzheimer’s Disease Risk. Frontiers in Genetics 2021; 12 doi: 10.3389/fgene.2021.700371
|
| 4 |
Artur Drużdż, Małgorzata Dudzic, Joanna Poszwa, Anna Rajewska, Aleksandra Mikołajczak, Wojciech Kozubski, Jolanta Dorszewska. GDF15 – A potential novel biomarker of cognitive impairment in cervical dystonia. Frontiers in Neuroscience 2026; 20 doi: 10.3389/fnins.2026.1771471
|
| 5 |
Noriyuki Miyaue, Hayato Yabe, Masahiro Nagai. Serum GDF-15 Levels in Patients with Parkinson’s Disease, Progressive Supranuclear Palsy, and Multiple System Atrophy. Neurology International 2023; 15(3) doi: 10.3390/neurolint15030066
|
| 6 |
Finula I. Isik, Shannon Thomson, John F. Cueto, Jessica Spathos, Samuel N. Breit, Vicky W. W. Tsai, David A. Brown, Caitlin A. Finney. A systematic review of the neuroprotective role and biomarker potential of GDF15 in neurodegeneration. Frontiers in Immunology 2024; 15 doi: 10.3389/fimmu.2024.1514518
|